BridgeBio Pharma, Inc. Prices $500 Million Convertible Senior Notes Offering to Lower Debt and Enhance Financial Flexibility
26/2 09:00
BridgeBio Pharma announces $500 million convertible notes offering to refinance debt, lowering interest costs and extending maturity....